The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway | Annual Review of Biochemistry | 2010 | 1.9K |
SPECTRA ANDHUBBLE SPACE TELESCOPELIGHT CURVES OF SIX TYPE Ia SUPERNOVAE AT 0.511 | Astrophysical Journal | 2010 | 1K |
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma | New England Journal of Medicine | 2010 | 961 |
Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor | Science Signaling | 2010 | 903 |
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria | European Heart Journal | 2010 | 889 |
Effects of medical therapies on retinopathy progression in type 2 diabetes | New England Journal of Medicine | 2010 | 859 |
Diffusion-weighted MR imaging of the liver | Radiology | 2010 | 621 |
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen | Journal of Clinical Oncology | 2010 | 615 |
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study | Journal of Clinical Oncology | 2010 | 547 |
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer | Cancer Research | 2010 | 533 |
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management | Leukemia | 2010 | 505 |
Pathogenetic mechanisms in radiation fibrosis | Radiotherapy and Oncology | 2010 | 397 |
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial | International Journal of Cancer | 2010 | 383 |
The Supernova Legacy Survey 3-year sample: Type Ia supernovae photometric distances and cosmological constraints | Astronomy and Astrophysics | 2010 | 339 |
Current and emerging biomarkers in breast cancer: prognosis and prediction | Endocrine-Related Cancer | 2010 | 320 |
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine | British Journal of Cancer | 2010 | 312 |
SHED differentiate into functional odontoblasts and endothelium | Journal of Dental Research | 2010 | 302 |
Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline | Arteriosclerosis, Thrombosis, and Vascular Biology | 2010 | 279 |
Cancer biomarkers: can we turn recent failures into success? | Journal of the National Cancer Institute | 2010 | 277 |
Guidelines on the radical management of patients with lung cancer | Thorax | 2010 | 274 |
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life | Supportive Care in Cancer | 2010 | 264 |
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial | Lancet Oncology, The | 2010 | 262 |
Revised U.K. guidelines for the management of cutaneous melanoma 2010 | British Journal of Dermatology | 2010 | 259 |
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2010 | 247 |
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer | Clinical Cancer Research | 2010 | 240 |